Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present studies examined whether dependence could be induced by continuous i.v. infusion of phencyclidine (
PCP
) in rats as demonstrated by disruptions of operant behavior during withdrawal. Rats were trained to lever press for their daily food rations under fixed-ratio 30 schedules of reinforcement during four, daily, 0.5-hr sessions. In the first study, withdrawal from 10 days of
PCP
infusion at a rate of 0.5 mg/kg/hr resulted in markedly reduced response rates which typically occurred within 6 to 12 hr and recovered within 24 to 48 hr, providing evidence of dependence in the four rats tested. The
PCP
withdrawal effect was replicated systematically in seven additional rats which had been given individually maximally tolerated
PCP
infusion regimens. Additionally, when
PCP
was readministered during withdrawal, the downward trend in response rates was halted and rates increased rapidly to control levels, providing evidence of reversal of
PCP
withdrawal effects. When ketamine, another arylcyclohexylamine dissociative anesthetic, was administered during
PCP
withdrawal at a dose of 2.5 mg/kg/hr, it also was able to reverse
PCP
withdrawal effects, demonstrating
cross-dependence
from
PCP
to ketamine. Response rates were also reduced markedly relative to control levels during withdrawal from continuous i.v. ketamine infusion in three rats tested, providing evidence that dependence upon this drug could also be induced. Withdrawal of
PCP
and ketamine administration can disrupt operant behavior, providing further evidence for the ability of these drugs to produce dependence.
...
PMID:Behavioral dependence upon phencyclidine and ketamine in the rat. 361 25